RecruitingNCT07544680
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Endometrial Cancer Vaginal Fluid Specimen Collection Study: "ENVISION"
Sponsor
Exact Sciences Corporation
Enrollment
4,200 participants
Start Date
Mar 10, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This is a multicenter, prospective, specimen collection study for development and evaluation of tests used to detect endometrial cancer, other cancers, or their causes.
Eligibility
Sex: FEMALEMin Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with abnormal uterine bleeding (aub), atypical endometrial hyperplasia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07544680
Related Trials
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
NCT060966881 location
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
NCT06952504261 locations
A Phase 1 Study of the Safety and Tolerability of CTX-10726
NCT074198415 locations
Deep Neuromuscular Blockade and a Low-Residue Diet for the Surgical Field in vNOTES Hysterectomy
NCT077309703 locations
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT0465706882 locations